Pharma-Triad Successfully Negotiates with pCPA, Tens of Thousands Gain Access to Life Altering Therapies

Gilead, Merck and BMS have negotiated and come to an agreement with pCPA regarding a host of life changing and life saving Hepatitis-C medications. This is an agreement that will benefit tens of thousands of patients in Canada as it will potentially provide access to these medications for patient with mild versions of chronic hepatitis-C.  BC PharmaCare has declared coverage of these drugs for patients with the disease, regardless of the type or severity, beginning in 2018. Ontario has also declared it is making major changes and will extend coverage to all patients over the next 12 months.

Source Document

Leave a Reply

Your email address will not be published. Required fields are marked *